Your browser doesn't support javascript.
loading
Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant.
Lechleider, Robert J; Arlen, Philip M; Tsang, Kwong-Yok; Steinberg, Seth M; Yokokawa, Junko; Cereda, Vittore; Camphausen, Kevin; Schlom, Jeffrey; Dahut, William L; Gulley, James L.
Affiliation
  • Lechleider RJ; Laboratory of Tumor Immunology and Biology, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Clin Cancer Res ; 14(16): 5284-91, 2008 Aug 15.
Article in En | MEDLINE | ID: mdl-18698048
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Adjuvants, Immunologic / Interleukin-2 / Prostate-Specific Antigen / Cancer Vaccines Limits: Aged / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Adjuvants, Immunologic / Interleukin-2 / Prostate-Specific Antigen / Cancer Vaccines Limits: Aged / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2008 Document type: Article Affiliation country: Country of publication: